Evidence map›Paper›PMID 25873050›Full record

Trial reportTrials2015

Optimizing early child development for young children with non-anemic iron deficiency in the primary care practice setting (OptEC): study protocol for a randomized controlled trial.

Kawsari Abdullah, Kevin E Thorpe, Eva Mamak, Jonathon L Maguire, Catherine S Birken, Darcy Fehlings, Anthony J Hanley, Colin Macarthur, Stanley H Zlotkin, Patricia C Parkin

Registry-linked trialOpen access · goldAbstract readMulticenter StudyPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01481766 (Optimizing Early Child Development in the Primary Care Practice Setting), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01481766 nacompletednot on this map

Optimizing Early Child Development in the Primary Care Practice Setting: Pragmatic Randomized Trial of Iron Treatment for Young Children With Non-anemic Iron Deficiency (OptEC)

TypeinterventionalSponsorThe Hospital for Sick ChildrenRan2012 to 2018Enrolled127ConditionsNon-anemic Iron DeficiencyArmsFerrous Sulfate, Placebo, Dietary counseling
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kawsari AbdullahPediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. kawsari.abdullah@sickkids.ca.
Kevin E ThorpeLi Ka Shing Knowledge Institute of St Michael's Hospital, 30 Bond Street, M5B 1 W8, Toronto, Canada. kevin.thorpe@utoronto.ca.
Eva MamakDepartment of Psychology, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. eva.mamak@sickkids.ca.
Jonathon L MaguirePediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. jonathon.maguire@utoronto.ca.
Catherine S BirkenPediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. catherine.birken@sickkids.ca.
Darcy FehlingsInstitute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street Suite 425, M5T 3 M6, Toronto, Canada. dfehlings@hollandbloorview.ca.
Anthony J HanleyDalla Lana School of Public Health, University of Toronto, 155 College Street 6th floor, M5T 3 M7, Toronto, Canada. anthony.hanley@utoronto.ca.
Colin MacarthurPediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. colin.macarthur@sickkids.ca.
Stanley H ZlotkinDalla Lana School of Public Health, University of Toronto, 155 College Street 6th floor, M5T 3 M7, Toronto, Canada. Stanley.zlotkin@sickkids.ca.
Patricia C ParkinPediatric Outcomes Research Team, Division of Pediatric Medicine, Department of Pediatrics, The Hospital for Sick Children, 555 University Avenue, M5G 1X8, Toronto, Canada. patricia.parkin@sickkids.ca.
SickKids Foundation · CAUniversity of Toronto · CAPublic Health Ontario · CAHospital for Sick Children · CASt. Michael's Hospital · CA

Funding

Canadian Institutes of Health Research 115059
6 · The paper itself

Abstract

backgroundThree decades of research suggests that prevention of iron deficiency anemia (IDA) in the primary care setting may be an unrealized and unique opportunity to prevent poor developmental outcomes in children. A longitudinal study of infants with IDA showed that the developmental disadvantage persists long term despite iron therapy. Early stages of iron deficiency, termed non-anemic iron deficiency (NAID), provide an opportunity for early detection and treatment before progression to IDA. There is little research regarding NAID, which may be associated with delayed development in young children. The aim of this study is to compare the effectiveness of four months of oral iron treatment plus dietary advice, with placebo plus dietary advice, in improving developmental outcomes in children with NAID and to conduct an internal pilot study. METHODS/

designFrom a screening cohort, those identified with NAID (hemoglobin ≥110 g/L and serum ferritin <14 μg/L) are invited to participate in a pragmatic, multi-site, placebo controlled, blinded, parallel group, superiority randomized trial. Participating physicians are part of a primary healthcare research network called TARGet Kids! Children between 12 and 40 months of age and identified with NAID are randomized to receive four months of oral iron treatment at 6 mg/kg/day plus dietary advice, or placebo plus dietary advice (75 per group). The primary outcome, child developmental score, is assessed using the Mullen Scales of Early Learning at baseline and at four months after randomization. Secondary outcomes include an age appropriate behavior measure (Children's Behavior Questionnaire) and two laboratory measures (hemoglobin and serum ferritin levels). Change in developmental and laboratory measures from baseline to the end of the four-month follow-up period will be analyzed using linear regression (analysis of covariance method). DISCUSSION: This trial will provide evidence regarding the association between child development and NAID, and the effectiveness of oral iron to improve developmental outcomes in children with NAID. The sample size of the trial will be recalculated using estimates taken from an internal pilot study.

trial registrationThis trial was registered with Clinicaltrials.gov (identifier: NCT01481766 ) on 22 November 2011.

Indexed as

Iron DeficienciesAdministration, OralAnemia, Iron-DeficiencyChild DevelopmentChild, PreschoolClinical ProtocolsFerrous CompoundsHumansInfantIronPrimary Health CareFerrous Compoundsferrous sulfateIron

Identifiers

PMID25873050
PMCPMC4389731
OpenAlexW1976742609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.